Stoke Therapeutics's total assets for Q1 2025 were $406.89M, an increase of 49.84% from the previous quarter. STOK total liabilities were $56.81M for the fiscal quarter, a 33.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.